Shanghai Kinetic Medical Co - Asset Resilience Ratio
Shanghai Kinetic Medical Co (300326) has an Asset Resilience Ratio of 28.89% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300326 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Shanghai Kinetic Medical Co's Asset Resilience Ratio has changed over time. See Shanghai Kinetic Medical Co (300326) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Kinetic Medical Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300326 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥976.00 Million | 28.89% |
| Total Liquid Assets | CN¥976.00 Million | 28.89% |
Asset Resilience Insights
- Very High Liquidity: Shanghai Kinetic Medical Co maintains exceptional liquid asset reserves at 28.89% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Kinetic Medical Co Industry Peers by Asset Resilience Ratio
Compare Shanghai Kinetic Medical Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Shanghai Kinetic Medical Co (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Shanghai Kinetic Medical Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 25.11% | CN¥841.43 Million ≈ $123.13 Million |
CN¥3.35 Billion ≈ $490.33 Million |
+12.55pp |
| 2023-12-31 | 12.56% | CN¥421.23 Million ≈ $61.64 Million |
CN¥3.35 Billion ≈ $490.80 Million |
+4.81pp |
| 2022-12-31 | 7.75% | CN¥264.40 Million ≈ $38.69 Million |
CN¥3.41 Billion ≈ $499.30 Million |
+2.68pp |
| 2021-12-31 | 5.07% | CN¥177.80 Million ≈ $26.02 Million |
CN¥3.51 Billion ≈ $513.55 Million |
+0.41pp |
| 2020-12-31 | 4.66% | CN¥171.46 Million ≈ $25.09 Million |
CN¥3.68 Billion ≈ $538.62 Million |
+2.01pp |
| 2019-12-31 | 2.65% | CN¥99.82 Million ≈ $14.61 Million |
CN¥3.77 Billion ≈ $551.69 Million |
+1.70pp |
| 2018-12-31 | 0.95% | CN¥33.80 Million ≈ $4.95 Million |
CN¥3.57 Billion ≈ $522.37 Million |
-6.03pp |
| 2017-12-31 | 6.98% | CN¥188.00 Million ≈ $27.51 Million |
CN¥2.69 Billion ≈ $394.29 Million |
+5.40pp |
| 2016-12-31 | 1.58% | CN¥35.00 Million ≈ $5.12 Million |
CN¥2.22 Billion ≈ $324.41 Million |
+0.87pp |
| 2015-12-31 | 0.71% | CN¥12.00 Million ≈ $1.76 Million |
CN¥1.70 Billion ≈ $248.14 Million |
-0.05pp |
| 2014-12-31 | 0.76% | CN¥10.00 Million ≈ $1.46 Million |
CN¥1.31 Billion ≈ $192.07 Million |
-- |
About Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgica… Read more